A prophylactic needle-free nebulizer treatment to prevent COVID-19 in both virus-exposed and healthy patient populations. A unique targeted T-Cell immunotherapy biomedicine designed to help cure and prevent COVID-19.
By relying on T-cells rather than antibodies, FlowVax Ebola provides long lasting protection through enhanced immune targeting and surveillance of the hidden Ebola virus nucleocapsid protein. FLOVID-20 targets the SARS-CoV-2 virus in the same way.
Marburg is an Ebola-like virus suitable for weaponization by hostile forces. Working directly with the United States Dept. of Defense, we are developing FlowVax Marburg, a prophylactic nebulized biomedicine to protect at-risk military forces and civilians.
A revolutionary approach to breast cancer that utilizes T-cell biomedicines to provide highly efficacious therapy.